Controversies in upper GI oncology: First-line checkpoint inhibitor use in metastatic GEA: Guided by PD-L1 CPS or not? Editorial

   

Authors:	Petrillo, A.; Maron, S. B.; Sundar, R.
Title:	Controversies in upper GI oncology: First-line checkpoint inhibitor use in metastatic GEA: Guided by PD-L1 CPS or not?
Keywords:	note; oncology; medical literature; esophageal adenocarcinoma; stomach adenocarcinoma; programmed death 1 ligand 1; immune checkpoint inhibitor; european medicines agency; statistically significant result
Journal Title:	ESMO Open
Volume:	8
Issue:	3
ISSN:	2059-7029
Publisher:	European Society for Medical Oncology
Date Published:	2023-06-01
Start Page:	101211
Language:	English
DOI:	10.1016/j.esmoop.2023.101211
PUBMED:	37054477
PROVIDER:	scopus
PMCID:	PMC10123152
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85152712617&doi=10.1016%2fj.esmoop.2023.101211&partnerID=40&md5=9584003c67d0a9a861009b2a6ad23cea
Notes:	This work is a summary of a Podcast -- Export Date: 1 May 2023 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/205565